Business · 1 sources covering this

Cipla receives U.S. FDA approval for generic of asthma, COPD drug

This is first dry powder inhaler (DPI) approval from Cipla’s U.S.-based manufacturing network. The product is expected to be launched in the second quarter (Q2) of FY27 in the U.S

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

The HinduLean L·2h ago
Cipla receives U.S. FDA approval for generic of asthma, COPD drug
This is first dry powder inhaler (DPI) approval from Cipla’s U.S.-based manufacturing network. The product is expected to be launched in the second quarter (Q2) of FY27 in the U.S
Read at The Hindu →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/8967ee08d06b64d5d882425979ade293d1014588"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Cipla receives U.S. FDA approval for generic of asthma, COPD drug"></iframe>

Cipla receives U.S. FDA approval for generic of asthma, COPD drug

How 1 sources are covering this

Cipla receives U.S. FDA approval for generic of asthma, COPD drug

More from Business

SEBI did not penalise most finfluencers: CFA study

Alembic Pharma gets U.S. FDA nod for generic chronic constipation drug

Virat Kohli-Anushka Sharma buy sea-facing luxury ₹18.29 crore apartment in Mumbai’s Versova

CBI files charge sheet in NEET-UG leak case

Reader

Trust & legal

Across the network